- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07942610
Audio Hypnotherapy for Preoperative Anxiety and Inflammatory Markers in Elective Cesarean Section
The Effect of Hypnotherapy on the Production of Transcription Factor NF-kB, IL-6, IL-10, and Anxiety in Patients Undergoing Cesarean Section: A Randomized Controlled Trial
This randomized controlled trial tests whether listening to an audio hypnotherapy recording before a planned cesarean section reduces preoperative anxiety and changes blood markers of inflammation. Sixty pregnant women scheduled for elective cesarean section under spinal anesthesia at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia, will be randomly assigned in a 1:1 ratio to receive either two 30-minute audio hypnotherapy sessions (the evening before surgery and the morning of surgery) or standard care without hypnotherapy. Anxiety will be measured with the Amsterdam Preoperative Anxiety and Information Scale (APAIS). NF-kB, IL-6 and IL-10 will be measured in blood before the intervention and 24 hours after surgery.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Background: Preoperative anxiety is common in women undergoing cesarean section. Anxiety activates the hypothalamic-pituitary-adrenal (HPA) axis and is associated with activation of nuclear factor-kappa B (NF-kB), increased interleukin-6 (IL-6) and decreased interleukin-10 (IL-10). Premedication drugs used to reduce anxiety can cause allergy and sedation, and their fetal safety is debated. Hypnotherapy is a non-pharmacological option, but its effect on both anxiety and inflammatory markers in cesarean section has not been well studied.
Design: Single-center, parallel-group, randomized controlled trial with pretest-posttest measurement. Participants are allocated 1:1 by a computer-generated random sequence concealed in sequentially numbered, sealed, opaque envelopes prepared by a third party not involved in the study.
Procedures: Eligible patients are screened one day before surgery and sign informed consent. Baseline APAIS score and baseline blood samples for NF-kB, IL-6 and IL-10 are collected. The hypnotherapy group listens to a 30-minute hypnotherapy audio recording in the evening before surgery and again in the morning of surgery. The control group receives standard care without hypnotherapy. APAIS is repeated on the morning of surgery before entering the operating room. All patients receive spinal anesthesia and standard postoperative analgesia according to hospital protocol. Blood samples are repeated 24 hours after surgery. IL-6 and IL-10 are measured by ELISA; NF-kB is measured in peripheral blood lymphocytes.
Sample size: 27 per group based on a previous study (mean anxiety difference 5.76, SD 5.19). Allowing 10% dropout, 30 per group (60 total) will be enrolled.
Analysis: Between-group comparisons by independent t-test or Mann-Whitney U test; within-group pre-post comparisons by paired t-test or Wilcoxon test. P < 0.05 is considered significant.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Tjahya Aryasa EM, MD
- Número de teléfono: +6281339713553
- Correo electrónico: tjahya_em@unud.ac.id
Ubicaciones de estudio
-
-
Bali
-
Denpasar, Bali, Indonesia, 80114
- Prof. Dr. I.G.N.G. Ngoerah General Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Pregnant women scheduled for elective cesarean section at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali
- Planned spinal (subarachnoid block) anesthesia
- Willing to participate and to sign informed consent
Exclusion Criteria:
- Emergency cesarean section
- Planned general anesthesia
- Use of narcotic or psychotropic drugs
- Medical conditions affecting the HPA axis, such as endocrine disorders
- Need for postoperative intensive care unit admission
- Unwilling to undergo the hypnotherapy intervention
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Hypnotherapy Group
Participants listen to a 30-minute pre-recorded audio hypnotherapy session twice: in the evening before surgery and in the morning of surgery, in addition to standard perioperative care. |
Pre-recorded hypnotherapy audio with induction, deepening, positive suggestions for calmness and a smooth cesarean section, relaxing background music, and termination. Delivered for 30 minutes on two occasions: the evening before surgery and the morning of surgery. |
|
Sin intervención: Control Group
Participants receive standard perioperative care without hypnotherapy. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Preoperative Anxiety Score (APAIS)
Periodo de tiempo: Baseline (day before surgery, before the first session) and morning of surgery (after the second session, before entering the operating room)
|
Anxiety measured with the Indonesian version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anxiety subscale is the sum of items 1, 2, 4 and 5, each scored 1-5 (total 4-20). Higher scores indicate greater anxiety. |
Baseline (day before surgery, before the first session) and morning of surgery (after the second session, before entering the operating room)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in NF-kB Level
Periodo de tiempo: Baseline (day before surgery) and 24 hours after surgery
|
NF-kB measured in peripheral blood lymphocytes isolated from venous blood. |
Baseline (day before surgery) and 24 hours after surgery
|
|
Change in Serum IL-6
Periodo de tiempo: Baseline (day before surgery) and 24 hours after surgery
|
Serum interleukin-6 measured by ELISA (ng/L). |
Baseline (day before surgery) and 24 hours after surgery
|
|
Change in Serum IL-10
Periodo de tiempo: Baseline (day before surgery) and 24 hours after surgery
|
Serum interleukin-10 measured by ELISA (pg/mL). |
Baseline (day before surgery) and 24 hours after surgery
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Tjahya Aryasa EM, MD, Udayana University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 1671/UN14.2.2.VII.14/LT/2026
- DP.04.03/D.XVI.2.4.1/32522/202 (Otro identificador: Research Permit, Prof. Dr. I.G.N.G. Ngoerah General Hospital)
- 260505.194 (Otro identificador: Research ID, Prof. Dr. I.G.N.G. Ngoerah General Hospital)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data will not be shared because participant consent did not include data sharing. Aggregated results will be published.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .